Novo Nordisk Invests DKK 8.5bn in Danish Rare Disease Production Facility
Novo Nordisk’s DKK 8.5bn investment in Odense facility supports rare disease treatments and sustainability.
Novo Nordisk’s DKK 8.5bn investment in Odense facility supports rare disease treatments and sustainability.
A new saliva-based test quickly identifies paracetamol overdose, improving diagnosis and saving critical treatment time.
Sakura Finetek and MEDIPATH partner to standardise workflows, improving efficiency and cancer diagnosis accuracy.
Innovative urine test detects early lung cancer, offering affordable and accessible solutions to improve patient outcomes.
Northern Ireland’s £55m investment in precision medicine accelerates personalised treatments and strengthens global healthcare innovation.
Durham University achieves record-breaking survey response rates, revolutionising global scientific consensus collection for policymaking.
WHO recommends HKBU’s rapid diagnostic system, capable of detecting 42 pathogens in under 90 minutes.
UK buys 5 million H5 influenza vaccine doses, boosting preparedness for potential future pandemics.
UCL scientists craft pasta thinner than light waves, with promising applications beyond the kitchen.
Genetic study reveals the collective role of thousands of genes in heart transplant-linked disease DCM.
Discover how scientists use bacteria-inspired innovations to transform sunlight into lasers for space exploration.
Discover how multimillion investments and innovations are advancing the UK’s life sciences and technology sectors.
Nobel Prizes honour breakthroughs in AI, gene regulation, and protein science, reshaping future scientific possibilities.
NIHR announces £11M in funding for groundbreaking projects aimed at boosting early cancer detection and diagnosis.
Reflective roofs could have prevented nearly 250 deaths during London’s hottest summer, new research reveals.
European Laboratory Day celebrates lab professionals’ contributions to diagnostics, healthcare innovation, and public health across Europe.
Roche’s cobas Respiratory flex test with TAGS technology enables rapid detection of 12 respiratory viruses.
NHSBT researchers uncover the genetic background of the rare AnWj antigen, establishing the new MAL blood group.
Pharmacy-led diabetes screening could save the NHS £50m annually, reducing GP burden and improving care.
Bristol secures two wins at the National AI Awards, cementing its leadership in AI research.